Testing effectiveness (Phase 2)Ended earlyNCT00003516
What this trial is testing
Antineoplaston Therapy in Treating Patients With Stage III or Stage IV Prostate Cancer
Who this might be right for
Prostate Cancer
Burzynski Research Institute 16
Showing 15 of 15 results